A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
Clinical trial NCT04132050 · COMPLETED
Trial details
- NCT number
- NCT04132050
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-24
- Primary completion
- 2021-12-21
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.